Noradrenergic component in the vasoconstriction induced by 5-hydroxytryptamine in goat cerebral arteries
- PMID: 6118410
- DOI: 10.1111/j.2042-7158.1981.tb13911.x
Noradrenergic component in the vasoconstriction induced by 5-hydroxytryptamine in goat cerebral arteries
Abstract
5-Hydroxytryptamine (5-HT) elicited dose-dependent increases in tension in the middle cerebral artery of the goat, which were significantly antagonized by lysergic acid diethylamide (LSD, 10(-8) M) and methysergide (10(-7) M). In the presence of phentolamine (10(-6) M), the dose-response curve to 5-HT was shifted to the right, the pA2 value for this antagonism was 6.52. Pretreatment of goats with reserpine (0.02 mg kg-1 day-1 for three days) or removal of both superior cervical ganglia 15 days before the experiment brought about a significant decrease in the vasoconstriction induced by doses of 5-HT higher than 10(-7) M. The remaining contraction produced by 5-HT in arterial segments from reserpinized or gangliectomized goats was further reduced in the presence of LSD. In addition, high concentrations of 5-HT induced tritium release from goat pial arteries preloaded with (-)-[3H]noradrenaline, 2 X 10(-7) M) which was significantly decreased in vessels from gangliectomized or reserpinized goats. These results in goat cerebral arteries indicate that in the contraction evoked by 5-HT there are two components. The first appears with low concentrations (up to 10(-7) M) in which 5-HT acts directly on 5-HT receptors. The second occurs at high doses (greater than 10(-7) M) in which 5-HT also acts indirectly on alpha-adrenoceptors by release of noradrenaline from noradrenergic nerve endings.
Similar articles
-
Analysis of the contractile effect of 5-hydroxytryptamine on the isolated posterior communicating artery of the cat.J Pharm Pharmacol. 1979 Jul;31(7):456-9. doi: 10.1111/j.2042-7158.1979.tb13553.x. J Pharm Pharmacol. 1979. PMID: 38315
-
Analysis of the cerebrovascular effects of 5-hydroxytryptamine in unanesthetized goats.J Pharmacol Exp Ther. 1981 Mar;216(3):599-603. J Pharmacol Exp Ther. 1981. PMID: 6259325
-
Serotonin antagonism in isolated canine cerebral arteries.Jpn J Pharmacol. 1976 Feb;(1):57-63. doi: 10.1254/jjp.26.57. Jpn J Pharmacol. 1976. PMID: 1263357
-
Adrenergic vasoconstriction of the goat middle cerebral artery.Am J Physiol. 1978 Aug;235(2):H131-5. doi: 10.1152/ajpheart.1978.235.2.H131. Am J Physiol. 1978. PMID: 210678
-
Innervation of cerebral arteries by nerves containing 5-hydroxytryptamine and noradrenaline.Pharmacol Ther. 1995;68(3):473-501. doi: 10.1016/0163-7258(95)02017-9. Pharmacol Ther. 1995. PMID: 8788567 Review.
Cited by
-
Differences in agonist dissociation constant estimates for 5-HT at 5-HT2-receptors: a problem of acute desensitization?Br J Pharmacol. 1988 Oct;95(2):569-77. doi: 10.1111/j.1476-5381.1988.tb11678.x. Br J Pharmacol. 1988. PMID: 3228675 Free PMC article.
-
An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. 1985.Br J Pharmacol. 2010 Jul;160 Suppl 1(Suppl 1):S54-64. doi: 10.1111/j.1476-5381.2010.00855.x. Br J Pharmacol. 2010. PMID: 20590656 Free PMC article. No abstract available.
-
An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.Br J Pharmacol. 1985 Feb;84(2):561-71. doi: 10.1111/j.1476-5381.1985.tb12941.x. Br J Pharmacol. 1985. PMID: 3978322 Free PMC article.
-
Effects of 5-hydroxytryptamine on human isolated placental chorionic arteries and veins.Br J Pharmacol. 1989 Apr;96(4):961-9. doi: 10.1111/j.1476-5381.1989.tb11908.x. Br J Pharmacol. 1989. PMID: 2743086 Free PMC article.
-
Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.Br J Pharmacol. 1987 Jun;91(2):321-31. doi: 10.1111/j.1476-5381.1987.tb10287.x. Br J Pharmacol. 1987. PMID: 3607360 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources